Insider Trading activities of Turning Point Therapeutics, Inc. (TPTX)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Turning Point Therapeutics, Inc. (TPTX) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Turning Point Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Turning Point Therapeutics, Inc. since 2005. The reporting company's ticker symbol is TPTX. The reporting company's CIK number is 1595893.
The total value of stock buying since 2005 is $33,206,400.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $51,073.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Turning Point Therapeutics, Inc. (TPTX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-05 0 $0 0 $0 23,268 $51,073
2019-04 1,844,800 $33,206,400 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Turning Point Therapeutics, Inc. insiders (TPTX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-05-14 Chen Bihua Option Ex 23,268 2.19 51,073
2019-04-22 Baker Brian Lee (VP of Finance and Admin.) Buy 2,800 18.00 50,400
2019-04-22 Lu Hongbo (Director) Buy 60,000 18.00 1,080,000
2019-04-22 Orbimed Capital Gp Vi Llc (Director) Buy 360,000 18.00 6,480,000
2019-04-22 Chen Bihua Buy 400,000 18.00 7,200,000
2019-04-22 George Simeon (Director) Buy 325,000 18.00 5,850,000
2019-04-22 Countouriotis Athena (President & CEO) Buy 12,000 18.00 216,000
2019-04-22 Gordon Carl L (Director) Buy 360,000 18.00 6,480,000
2019-04-22 Glaxosmithkline Plc Buy 325,000 18.00 5,850,000

Insider trading activities including stock purchases, stock sales, and option exercises of TPTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Turning Point Therapeutics, Inc. (symbol TPTX, CIK number 1595893) see the Securities and Exchange Commission (SEC) website.